NOVEL INHIBITORS
Compounds of general formula (I): wherein R1, R2, R3, R4, X and Y are as defined herein are inhibitors of glutaminyl cyclase and are therefore useful in treating conditions that can be treated by modulation of glutaminyl cyclase activity. La présente invention concerne des composés de formule généra...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DEMUTH, HANS-ULRICH HEISER, ULRICH GAERTNER, ULF-TORSTEN HAMANN, ANTJE TREML, ANDREAS SOMMER, ROBERT ALMSTETTER, MICHAEL HOFFMANN, TORSTEN THORMANN, MICHAEL |
| description | Compounds of general formula (I): wherein R1, R2, R3, R4, X and Y are as defined herein are inhibitors of glutaminyl cyclase and are therefore useful in treating conditions that can be treated by modulation of glutaminyl cyclase activity.
La présente invention concerne des composés de formule générale (I) : dans laquelle R1, R2, R3, R4 X et Y tels que définis dans le présent document sont des inhibiteurs de la glutaminyl cyclase et sont par conséquent utiles pour le traitement de conditions qui peuvent être traitées par modulation de lactivité de la glutaminyl cyclase. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2735795C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2735795C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2735795C3</originalsourceid><addsrcrecordid>eNrjZBDw8w9z9VHw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORubGpuaWps7GhFUAAJuJHMg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL INHIBITORS</title><source>esp@cenet</source><creator>DEMUTH, HANS-ULRICH ; HEISER, ULRICH ; GAERTNER, ULF-TORSTEN ; HAMANN, ANTJE ; TREML, ANDREAS ; SOMMER, ROBERT ; ALMSTETTER, MICHAEL ; HOFFMANN, TORSTEN ; THORMANN, MICHAEL</creator><creatorcontrib>DEMUTH, HANS-ULRICH ; HEISER, ULRICH ; GAERTNER, ULF-TORSTEN ; HAMANN, ANTJE ; TREML, ANDREAS ; SOMMER, ROBERT ; ALMSTETTER, MICHAEL ; HOFFMANN, TORSTEN ; THORMANN, MICHAEL</creatorcontrib><description>Compounds of general formula (I): wherein R1, R2, R3, R4, X and Y are as defined herein are inhibitors of glutaminyl cyclase and are therefore useful in treating conditions that can be treated by modulation of glutaminyl cyclase activity.
La présente invention concerne des composés de formule générale (I) : dans laquelle R1, R2, R3, R4 X et Y tels que définis dans le présent document sont des inhibiteurs de la glutaminyl cyclase et sont par conséquent utiles pour le traitement de conditions qui peuvent être traitées par modulation de lactivité de la glutaminyl cyclase.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180220&DB=EPODOC&CC=CA&NR=2735795C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180220&DB=EPODOC&CC=CA&NR=2735795C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DEMUTH, HANS-ULRICH</creatorcontrib><creatorcontrib>HEISER, ULRICH</creatorcontrib><creatorcontrib>GAERTNER, ULF-TORSTEN</creatorcontrib><creatorcontrib>HAMANN, ANTJE</creatorcontrib><creatorcontrib>TREML, ANDREAS</creatorcontrib><creatorcontrib>SOMMER, ROBERT</creatorcontrib><creatorcontrib>ALMSTETTER, MICHAEL</creatorcontrib><creatorcontrib>HOFFMANN, TORSTEN</creatorcontrib><creatorcontrib>THORMANN, MICHAEL</creatorcontrib><title>NOVEL INHIBITORS</title><description>Compounds of general formula (I): wherein R1, R2, R3, R4, X and Y are as defined herein are inhibitors of glutaminyl cyclase and are therefore useful in treating conditions that can be treated by modulation of glutaminyl cyclase activity.
La présente invention concerne des composés de formule générale (I) : dans laquelle R1, R2, R3, R4 X et Y tels que définis dans le présent document sont des inhibiteurs de la glutaminyl cyclase et sont par conséquent utiles pour le traitement de conditions qui peuvent être traitées par modulation de lactivité de la glutaminyl cyclase.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBDw8w9z9VHw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8c6ORubGpuaWps7GhFUAAJuJHMg</recordid><startdate>20180220</startdate><enddate>20180220</enddate><creator>DEMUTH, HANS-ULRICH</creator><creator>HEISER, ULRICH</creator><creator>GAERTNER, ULF-TORSTEN</creator><creator>HAMANN, ANTJE</creator><creator>TREML, ANDREAS</creator><creator>SOMMER, ROBERT</creator><creator>ALMSTETTER, MICHAEL</creator><creator>HOFFMANN, TORSTEN</creator><creator>THORMANN, MICHAEL</creator><scope>EVB</scope></search><sort><creationdate>20180220</creationdate><title>NOVEL INHIBITORS</title><author>DEMUTH, HANS-ULRICH ; HEISER, ULRICH ; GAERTNER, ULF-TORSTEN ; HAMANN, ANTJE ; TREML, ANDREAS ; SOMMER, ROBERT ; ALMSTETTER, MICHAEL ; HOFFMANN, TORSTEN ; THORMANN, MICHAEL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2735795C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DEMUTH, HANS-ULRICH</creatorcontrib><creatorcontrib>HEISER, ULRICH</creatorcontrib><creatorcontrib>GAERTNER, ULF-TORSTEN</creatorcontrib><creatorcontrib>HAMANN, ANTJE</creatorcontrib><creatorcontrib>TREML, ANDREAS</creatorcontrib><creatorcontrib>SOMMER, ROBERT</creatorcontrib><creatorcontrib>ALMSTETTER, MICHAEL</creatorcontrib><creatorcontrib>HOFFMANN, TORSTEN</creatorcontrib><creatorcontrib>THORMANN, MICHAEL</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DEMUTH, HANS-ULRICH</au><au>HEISER, ULRICH</au><au>GAERTNER, ULF-TORSTEN</au><au>HAMANN, ANTJE</au><au>TREML, ANDREAS</au><au>SOMMER, ROBERT</au><au>ALMSTETTER, MICHAEL</au><au>HOFFMANN, TORSTEN</au><au>THORMANN, MICHAEL</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL INHIBITORS</title><date>2018-02-20</date><risdate>2018</risdate><abstract>Compounds of general formula (I): wherein R1, R2, R3, R4, X and Y are as defined herein are inhibitors of glutaminyl cyclase and are therefore useful in treating conditions that can be treated by modulation of glutaminyl cyclase activity.
La présente invention concerne des composés de formule générale (I) : dans laquelle R1, R2, R3, R4 X et Y tels que définis dans le présent document sont des inhibiteurs de la glutaminyl cyclase et sont par conséquent utiles pour le traitement de conditions qui peuvent être traitées par modulation de lactivité de la glutaminyl cyclase.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA2735795C |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | NOVEL INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T08%3A30%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DEMUTH,%20HANS-ULRICH&rft.date=2018-02-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2735795C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |